References

microbe

Проблемы особо опасных инфекций

Problems of Particularly Dangerous Infections

0370-10692658-719X

Russian Research Anti-Plague Institute “Microbe”

10.21055/0370-1069-2015-3-16-23

microbe-239

Research Article

ЭПИДЕМИОЛОГИЯ

EPIDEMIOLOGY

Использование системного подхода в оценке надзора и контроля болезни, вызванной вирусом Эбола

Deployment of Systematic Approach to the Assessment of Surveillance and Control over Ebola Virus Disease

Карнаухов

И. Г.

Karnaukhov

I. G.

rusrapi@microbe.ru

Топорков

В. П.

Toporkov

V. P.

rusrapi@microbe.ru

Удовиченко

С. К.

Udovichenko

S. K.

rusrapi@microbe.ru

Кутырев

В. В.

Kutyrev

V. V.

rusrapi@microbe.ru

Российский научно-исследовательский противочумный институт «Микроб»РоссияRussian Research Anti-Plague Institute “Microbe”Russian Federation

2015

20092015

031623

2015

Карнаухов И.Г., Топорков В.П., Удовиченко С.К., Кутырев В.В.

Karnaukhov I.G., Toporkov V.P., Udovichenko S.K., Kutyrev V.V.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://journal.microbe.ru/jour/article/view/239

В статье рассмотрен системный подход в отношении надзора и контроля ЧС в области санитарно-эпидемиологического благополучия на примере эпидемии лихорадки Эбола в странах Западной Африки. На основании данных литературы проанализированы меры по надзору и контролю БВВЭ в отношении каждого из четырех элементов эпидемического процесса (источник, возбудитель, механизм передачи, реципиент) на различных уровнях организации материи (глобальный, региональный, популяционный, организменный, клеточный, молекулярный, субмолекулярный). На основании проведенного анализа предложены основные направления по оптимизации надзора и контроля БВВЭ.

Studied has been systematic approach as regards epidemiological surveillance and control over emergency situations in the sphere of sanitary-epidemiological welfare by the example of Ebola fever epidemic in West Africa countries. Based on the literature data available, analyzed have been measures for EVD surveillance and control, with reference to every stage of epidemiological process (source/ origin, agent, mechanism of transmission, recipient) at various levels of matter organization (global, regional, population, cellular, molecular, and sub-molecular). Following this, put forward have been primary areas for EVD control optimization.

системный подходэпидемический процессэпидемиологический надзор и контрольлихорадка ЭболаЧС в области санитарно-эпидемиологического благополучияsystematic approachepidemic processepidemiological surveillance and controlEbola feveremergency situation in the sphere of sanitary-epidemiological welfare

References1

Беляков В.Д. Эпидемический процесс. Л.: Медицина, 1964. 244 с.

Belyakov V.D. [Epidemic Process (Theory and Method of Investigation)]. L.: Meditsina, 1964. 244 p.

Болезнь, вызванная вирусом Эбола. Информационный бюллетень ВОЗ. Информационный бюллетень № 103. Август 2015. http://www.who.int/mediacentre/factsheets/fs103/ru/ (дата обращения 22.04.2015).

[Ebola virus disease. WHO Information Bulletin]. 2015; N 103. [cited 22 Apr 2015]. Available from: http://www.who.int/mediacentre/factsheets/fs103/ru/.

Вакцины, терапевтические средства и методы диагностики вируса Эбола. http://www.who.int/medicines/emp_ebola_q_as/ru/ (дата обращения 15.07.2015).

[Ebola vaccines, therapies, and diagnostics]. [cited 15 Jul 2015]. Available from: http://www.who.int/medicines/emp_ebola_q_as/ru/.

ВОЗ заявила о скором завершении эпидемии лихорадки Эбола. http://www.vz.ru/news/2015/1/29/726841.html (дата обращения 21.07.2015).

[WHO declared Ebola epidemic close to an end]. [cited 21 Jul 2015]. Available from: http://www.vz.ru/news/2015/1/29/726841.html.

Онищенко Г.Г., Кутырев В.В., редакторы. Санитарная охрана территории Российской Федерации в современных условиях. Саратов: ООО «Буква»; 2014. 460 с.

Onishchenko G.G., Kutyrev V.V., editors. [Sanitary Protection of the Russian Federation Territories under Current Conditions]. Saratov: Publishing House «Bukva» Ltd., 2014. 460 p.

Платонов А.Е., Платонова О.В., Малеев В.В. Эбола, 2014 г. Эпидемиологические и социальные аспекты. Эпидемиол. и инф. бол. 2014; 5:34-49.

Platonov A.E., Platonova O.V., Maleev V.V. [Ebola, 2014. Epidemiological and social aspects]. Epidemiol. Infek. Bol. 2014; 5:34–49.

Попова А.Ю., Кутырев В.В., редакторы. Эпидемиология, профилактика и лабораторная диагностика болезни, вызванной вирусом Эбола. Саратов: ООО «Буква»; 2015. 250 с.

Popova A.Yu., Kutyrev V.V., editors. [Epidemiology, Prophylaxis, and Laboratory Diagnostics of Ebola Virus Disease]. Saratov: Publishing House «Bukva» Ltd., 2015. 250 p.

Черкасский Б.Л. Руководство по общей эпидемиологии. М.: Медицина; 2001. 560 с.

Cherkassky B.L. [Guidelines on General Epidemiology]. M.: Meditsina, 2001. 560 p.

Черкасский Б.Л. Эпидемиологический словарь. М.: Научно-методический центр ТВКГ им. акад. Н.Н.Бурденко; 2001. 84 с.

Cherkassky B.L. [Epidemiological Dictionary]. M., 2001. 84 p.

Шкарин В.В., Ковалишена О.В. Новые инфекции: систематизация, проблемы, перспективы. Н. Новгород: Изд-во НГМА; 2012. 716 с.

Shkarin V.V., Kovalishena O.V. [Emerging Infections: Systematization, Challenging Issues, and Prospective]. N. Novgorod: Publishing House at the premises of Nizhny Novgorod State Medical Academy, 2012. 716 p.

Agnandji S.T., Huttner A., Zinser M.E., Njuguna P., Dahlke C., Fernandes J.F., Yerly S., Dayer J.A., Kraehling V., Kasonta R., Adegnika A.A., Altfeld M., Auderset F., Bache E.B., Biedenkopf N., Borregaard S., Brosnahan J.S., Burrow R., Combescure C., Desmeules J., Eickmann M., Fehling S.K., Finckh A., Goncalves A.R., Grobusch M.P., Hooper J., Jambrecina A., Kabwende A.L., Kaya G., Kimani D., Lell B., Lemaître B., Lohse A.W., Massinga-Loembe M., Matthey A., Mordmüller B., Nolting A., Ogwang C., Ramharter M., Schmidt-Chanasit J., Schmiedel S., Silvera P., Stahl F.R., Staines H.M., Strecker T., Stubbe H.C., Tsofa B., Zaki S., Fast P., Moorthy V., Kaiser L., Krishna S., Becker S., Kieny M.P., Bejon P., Kremsner P.G., Addo M.M., Siegrist C.A. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe - preliminary report. N. Engl. J. Med. April 1, 2015 [Epub ahead of print]. DOI: 10.1056/NEJMoa1502924. http://www.nejm.org/doi/full/10.1056/NEJMoa1502924#t=articleDiscussion (дата обращения 28.06.2015).

Agnandji S.T., Huttner A., Zinser M.E., Njuguna P., Dahlke C., Fernandes J.F., Yerly S., Dayer J.A., Kraehling V., Kasonta R., Adegnika A.A., Altfeld M., Auderset F., Bache E.B., Biedenkopf N., Borregaard S., Brosnahan J.S., Burrow R., Combescure C., Desmeules J., Eickmann M., Fehling S.K., Finckh A., Goncalves A.R., Grobusch M.P., Hooper J., Jambrecina A., Kabwende A.L., Kaya G., Kimani D., Lell B., Lemaître B., Lohse A.W., Massinga-Loembe M., Matthey A., Mordmüller B., Nolting A., Ogwang C., Ramharter M., Schmidt-Chanasit J., Schmiedel S., Silvera P., Stahl F.R., Staines H.M., Strecker T., Stubbe H.C., Tsofa B., Zaki S., Fast P., Moorthy V., Kaiser L., Krishna S., Becker S., Kieny M.P., Bejon P., Kremsner P.G., Addo M.M., Siegrist C.A. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe – preliminary report. N. Engl. J. Med. April 1, 2015 [Epub ahead of print] [cited 28 Jun 2015]. DOI: 10.1056/NEJMoa1502924. Available from: http://www.nejm.org/doi/full/10.1056/NEJMoa1502924#t=articleDiscussion.

Baize S., Leroy E.M., Georges A.J., Georges-Courbot M.C., Capron M., Bedjabaga I., Lansoud-Soukate J., Mavoungou E. Inflammatory responses in Ebola virus-infected patients. Clin. Exp. Immunol. 2002; 128(1):163-8.

Basler C.F. Portrait of a killer: genome of the 2014 EBOV outbreak strain. Cell Host Microbe. 2014; 16(4):419-21.

Basler C.F. Portrait of a killer: genome of the 2014 EBOV outbreak strain. Cell Host Microbe. 2014; 16(4):419–21.

Bausch D.G., Schwarz L. Outbreak of Ebola virus disease in Guinea: where ecology meets economy. PLoS Negl. Trop. Dis. 2014; 8(7):e3056. DOI: 10.1371/journal.pntd.0003056.

Becquart P., Wauquier N., Mahlakoiv T., Nkoghe D., Padilla C., Souris M., Ollomo B., Gonzalez J.P., De Lamballerie X., Kazanji M., Leroy E.M. High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon. PLoS One. 2010; 5(2):e9126. DOI: 10.1371/journal.pone.0009126.

Bellan S.E., Pulliam J.R., Dushoff J., Meyers L.A. Ebola control: effect of asymptomatic infection and acquired immunity. Lancet. 2014; 384(9953):1499-500.

Bellan S.E., Pulliam J.R., Dushoff J., Meyers L.A. Ebola control: effect of asymptomatic infection and acquired immunity. Lancet. 2014; 384(9953):1499–500.

Chan M. Ebola virus disease in West Africa - No early end to the outbreak. N. Engl. J. Med. 2014; 371(13):1183-5.

Chan M. Ebola virus disease in West Africa – No early end to the outbreak. N. Engl. J. Med. 2014; 371(13):1183–5.

Del Rio C., Mehta A.K., Lyon G.M. III, Guarner J. Ebola hemorrhagic fever in 2014: The tale of an evolving epidemic. Ann. Intern. Med. 2014; 161(10):746-8.

Del Rio C., Mehta A.K., Lyon G.M. III, Guarner J. Ebola hemorrhagic fever in 2014: The tale of an evolving epidemic. Ann. Intern. Med. 2014; 161(10):746–8.

Ebola virus - a short primer on virus survival and disinfection. http://pennstatefoodsafety.blogspot.ru/2014/10/ebola-virus-short-primer-on-virus.html (дата обращения 15.04.2015).

Ebola virus – a short primer on virus survival and disinfection. [cited 15 Apr 2015]. Available from: http://pennstatefoodsafety.blogspot.ru/2014/10/ebola-virus-short-primer-on-virus.html.

Filovirus haemorrhagic fever. Guideline (Draft for internal use). Medicins Sans Frontieres (MSF OCBA); 2008. 133 p.

Gonzalez J.P., Herbreteau V., Morvan J., Leroy E.M. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence. Bull. Soc. Pathol. Exot. 2005; 98(3):210-7.

Gonzalez J.P., Herbreteau V., Morvan J., Leroy E.M. Ebola virus circulation in Africa: a balance between clinical expression and epidemiological silence. Bull. Soc. Pathol. Exot. 2005; 98(3):210–7.

Goodman J.L. Studying «Secret serums» - toward safe, effective Ebola treatments. N. Engl. J. Med. 2014; 371(12):1086-9.

Goodman J.L. Studying «Secret serums» – toward safe, effective Ebola treatments. N. Engl. J. Med. 2014; 371(12):1086–9.

Hayman D.T., Emmerich P., Yu M., Wang L., Suu-Ire R., Fooks A.R. Cunningham A.A., Wood J. Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One. 2010; 5(8):e11978. DOI: 10.1371/journal.pone.0011978.

Heterologous prime-boost immunisation in Ebola vaccine development, testing and licensure. http://www.who.int/immunization/research/meetings_workshops/WHO_primeboost_Ebola_21nov14_meeting_report.pdf (дата обращения 19.07.2015).

Heterologous prime-boost immunisation in Ebola vaccine development, testing and licensure. [cited 19 Jul 2015]. Available from: http://www.who.int/immunization/research/meetings_workshops/WHO_primeboost_Ebola_21nov14_meeting_report.pdf.

Interim guidance for environmental infection control in hospitals for Ebola virus. http://www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-in-hospitals.html (дата обращения 25.05.2015).

Interim guidance for environmental infection control in hospitals for Ebola virus. [cited 25 May 2015]. Available from: http://www.cdc.gov/vhf/ebola/hcp/environmental-infection-control-in-hospitals.html.

Lahm S.A., Kombila M., Swanepoel R., Barnes R.F. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994-2003. Trans R Soc Trop Med Hyg. 2007; 101:64-78.

Lahm S.A., Kombila M., Swanepoel R., Barnes R.F. Morbidity and mortality of wild animals in relation to outbreaks of Ebola haemorrhagic fever in Gabon, 1994–2003. Trans R Soc Trop Med Hyg. 2007; 101:64–78.

Leroy E.M., Epelboin A., Mondonge V., Pourrut X., Gonzalez J.P., Muyembe-Tamfum J.J., Formenty P. Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis. 2009; 9(6):723-8.

Leroy E.M., Rouquet P., Formenty P., Souquière S., Kilbourne A., Froment J.M., Bermejo M., Smit S., Karesh W., Swanepoel R., Zaki S.R., Rollin P.E. Multiple Ebola virus transmission events and rapid decline of Central African wildlife. Science. 2004; 303(5656):387-90.

Olival K.J., Hayman D.T. Filoviruses in bats: current knowledge and future directions. Viruses. 2014; 6:1759-88.

Olival K.J., Hayman D.T. Filoviruses in bats: current knowledge and future directions. Viruses. 2014; 6:1759–88.

Peterson A.T., Carroll D.S., Mills J.N., Johnson K.M. Potential mammalian filovirus reservoirs. Emerg. Infect. Dis. 2004; 10(12):2073-81.

Peterson A.T., Carroll D.S., Mills J.N., Johnson K.M. Potential mammalian filovirus reservoirs. Emerg. Infect. Dis. 2004; 10(12):2073–81.

Possible natural immunity to Ebola? http://en.ird.fr/the-media-centre/scientific-newssheets/337-possible-natural-immunity-to-ebola (дата обращения 10.06.2015).

Possible natural immunity to Ebola? [cited 10 Jun 2015]. Available from: http://en.ird.fr/the-media-centre/scientific-newssheets/337-possiblenatural-immunity-to-ebola.

Pourrut X., Kumulungui B., Wittmann T., Moussavou G., Délicat A., Yaba P., Nkoghe D., Gonzalez J.P., Leroy E.M. The natural history of Ebola virus in Africa. Microbes Infect. 2005; 7:1005-14.

Pourrut X., Kumulungui B., Wittmann T., Moussavou G., Délicat A., Yaba P., Nkoghe D., Gonzalez J.P., Leroy E.M. The natural history of Ebola virus in Africa. Microbes Infect. 2005; 7:1005–14.

Pourrut X., Souris M., Towner J.S., Rollin P.E., Nichol S.T., Gonzalez J.P., Leroy E. Large serological survey showing cocirculation of Ebola and Marburg viruses in gabonese bat populations and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect. Dis. 2009; 9:159. DOI: 10.1186/1471-2334-9-159.

Prescott J., Bushmaker N., Fischer R., Miazgowicz K., Judson S., Munster V.J. Postmortem stability of Ebola virus. Emerg Inf. Dis. 2015; 21(5):856-9.

Prescott J., Bushmaker N., Fischer R., Miazgowicz K., Judson S., Munster V.J. Postmortem stability of Ebola virus. Emerg Inf. Dis. 2015; 21(5):856–9.

Reardon S. Ebola treatments caught in limbo. Nature. 2014; 511(7511):520.

Reiter P., Turell M., Coleman R., Miller B., Maupin G., Liz J., Kuehne A., Barth J., Geisbert J., Dohm D., Glick J., Pecor J., Robbins R., Jahrling P., Peters C., Ksiazek T. Field investigations of an outbreak of Ebola Hemorrhagic fever, Kikwit, Democratic Republic of the Congo: arthropod studies. J. Infect. Dis. 1999, 179(l):S148-54.

Schoepp R.J., Rossi C.A., Khan S.H., Goba A., Fair J.N. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg. Infect. Dis. 2014; 20(7):1176-82.

Schoepp R.J., Rossi C.A., Khan S.H., Goba A., Fair J.N. Undiagnosed acute viral febrile illnesses, Sierra Leone. Emerg. Infect. Dis. 2014; 20(7):1176–82.

Walsh P.D., Abernethy K.A., Bermejo M., Beyers R., Wachter P.D., Akou M.E., Huijbregts B., Mambounga D.I., Toham A.K., Kilbourn A.M., Lahm S.A., Latour S., Maisels F., Mbina C., Mihindou Y., Obiang S.N., Effa E.N., Starkey M.P., Telfer P., Thibault M., Tutin C., Whitek L., Wilkiek D.S. Catastrophic ape decline in western equatorial Africa. Nature. 2003; 422:611-14.

World Health Organization. Ebola Response Roadmap. http://apps.who.int/iris/bitstream/10665/131596/1/EbolaResponse Roadmap.pdf (дата обращения 14.07.2015).

World Health Organization. Ebola Response Roadmap. [cited 14 Jul 2015]. Available from: http://apps.who.int/iris/bitstream/10665/131596/1/EbolaResponseRoadmap.pdf.

World Health Organization. Ebola Response Roadmap Situation Report 3. http://apps.who.int/iris/bitstream/10665/133073/1/roadmapsitrep3_eng.pdf?ua=1 (дата обращения 5.05.2015).

World Health Organization. Ebola Response Roadmap Situation Report 3. [cited 05 May 2015]. Available from: http://apps.who.int/iris/bitstream/10665/133073/1/roadmapsitrep3_eng.pdf?ua=1.

World Health Organization. Unprecedented number of medical staff infected with Ebola. http://www.who.int/mediacentre/news/ebola/25-august-2014/en/# (дата обращения 26.05.2015).

World Health Organization. Unprecedented number of medical staff infected with Ebola. [cited 26 May 2015]. Available from: http://www.who.int/mediacentre/news/ebola/25-august-2014/en/#.

The authors declare that there are no conflicts of interest present.